328 related articles for article (PubMed ID: 12635171)
1. Specialization of tumour vasculature.
Ruoslahti E
Nat Rev Cancer; 2002 Feb; 2(2):83-90. PubMed ID: 12635171
[TBL] [Abstract][Full Text] [Related]
2. Targeting tumor vasculature with homing peptides from phage display.
Ruoslahti E
Semin Cancer Biol; 2000 Dec; 10(6):435-42. PubMed ID: 11170865
[TBL] [Abstract][Full Text] [Related]
3. Expression of vascular endothelial growth factor receptor 3 in blood and lymphatic vessels of lung adenocarcinoma.
Niki T; Iba S; Yamada T; Matsuno Y; Enholm B; Hirohashi S
J Pathol; 2001 Apr; 193(4):450-7. PubMed ID: 11276003
[TBL] [Abstract][Full Text] [Related]
4. Vascular zip codes in angiogenesis and metastasis.
Ruoslahti E
Biochem Soc Trans; 2004 Jun; 32(Pt3):397-402. PubMed ID: 15157146
[TBL] [Abstract][Full Text] [Related]
5. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
6. Lymphangiogenesis in malignant tumours: Does it occur?
Clarijs R; Ruiter DJ; de Waal RM
J Pathol; 2001 Feb; 193(2):143-6. PubMed ID: 11180158
[TBL] [Abstract][Full Text] [Related]
7. New molecular markers for the study of tumour lymphangiogenesis.
Jackson DG
Anticancer Res; 2001; 21(6B):4279-83. PubMed ID: 11908682
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.
Lincoln DT; Singal PK; Al-Banaw A
Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592
[TBL] [Abstract][Full Text] [Related]
9. Peptide-based molecules in angiogenesis.
D'Andrea LD; Del Gatto A; Pedone C; Benedetti E
Chem Biol Drug Des; 2006 Feb; 67(2):115-26. PubMed ID: 16492159
[TBL] [Abstract][Full Text] [Related]
10. Lymphatic versus blood vascular endothelial growth factors and receptors in humans.
Partanen TA; Paavonen K
Microsc Res Tech; 2001 Oct; 55(2):108-21. PubMed ID: 11596156
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of Hela-type caldesmon in tumour neovascularization: a new marker of angiogenic endothelial cells.
Zheng PP; van der Weiden M; Kros JM
J Pathol; 2005 Feb; 205(3):408-14. PubMed ID: 15682433
[TBL] [Abstract][Full Text] [Related]
12. Tumour-associated angiogenesis in human colorectal cancer.
Rmali KA; Puntis MC; Jiang WG
Colorectal Dis; 2007 Jan; 9(1):3-14. PubMed ID: 17181841
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium.
Paavonen K; Mandelin J; Partanen T; Jussila L; Li TF; Ristimaki A; Alitalo K; Konttinen YT
J Rheumatol; 2002 Jan; 29(1):39-45. PubMed ID: 11824969
[TBL] [Abstract][Full Text] [Related]
14. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
Pradeep CR; Sunila ES; Kuttan G
Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
[TBL] [Abstract][Full Text] [Related]
15. [Role of the vascular component in growth of solid tumors: a historical review].
Ribatti D; Vacca A
Ann Ital Med Int; 1994; 9(2):92-5. PubMed ID: 7522501
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analysis of VEGF-C/VEGFR-3 system and lymphatic vessel extent in normal and adenomatous human pituitary tissues.
Onofri C; Losa M; Uhl E; Stalla GK; Renner U
Exp Clin Endocrinol Diabetes; 2008 Mar; 116(3):152-7. PubMed ID: 18205092
[TBL] [Abstract][Full Text] [Related]
17. Role of hematopoietic lineage cells as accessory components in blood vessel formation.
Takakura N
Cancer Sci; 2006 Jul; 97(7):568-74. PubMed ID: 16827795
[TBL] [Abstract][Full Text] [Related]
18. Molecular addresses of tumors: selection by in vivo phage display.
Li XB; Schluesener HJ; Xu SQ
Arch Immunol Ther Exp (Warsz); 2006; 54(3):177-81. PubMed ID: 16736105
[TBL] [Abstract][Full Text] [Related]
19. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival.
Decaussin M; Sartelet H; Robert C; Moro D; Claraz C; Brambilla C; Brambilla E
J Pathol; 1999 Aug; 188(4):369-77. PubMed ID: 10440746
[TBL] [Abstract][Full Text] [Related]
20. Basement membranes: structure, assembly and role in tumour angiogenesis.
Kalluri R
Nat Rev Cancer; 2003 Jun; 3(6):422-33. PubMed ID: 12778132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
